Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasmapheresis in multiple sclerosis: preliminary study

H L Weiner, D M Dawson

    Neurology
    |October 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells.

    Mucosal immunology·2018
    Same author

    Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.

    Multiple sclerosis and related disorders·2018
    Same author

    Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.

    Experimental neurology·2014
    Same author

    The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis.

    AJNR. American journal of neuroradiology·2012
    Same author

    Antigen microarrays identify CNS-produced autoantibodies in RRMS.

    Neurology·2012
    Same author

    Demographic and clinical characteristics of malignant multiple sclerosis.

    Neurology·2011

    Plasmapheresis, prednisone, and azathioprine therapy showed moderate improvement in six of eight patients with chronic progressive multiple sclerosis (MS) unresponsive to steroids. Two patients maintained improvement long-term, warranting further trials.

    Area of Science:

    • Neurology
    • Immunology

    Background:

    • Chronic progressive multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system.
    • Corticosteroid therapy is a common treatment, but some patients are unresponsive.

    Observation:

    • Eight patients with chronic progressive MS unresponsive to corticosteroids received short-term plasmapheresis, prednisone, and azathioprine.
    • The study monitored patient response, evoked potentials, and cerebrospinal fluid (CSF) immunoglobulin G (IgG) levels.

    Findings:

    • Six of eight patients experienced moderate improvement.
    • Improvement persisted long-term in two patients, while four relapsed within 2-3 months.
    • Plasmapheresis lowered CSF IgG levels, but no consistent changes in evoked responses were observed.

    Related Experiment Videos

    Implications:

    • Short-term plasmapheresis combined with immunosuppressants may offer benefits for some MS patients.
    • Further controlled trials are necessary to establish the efficacy of plasmapheresis in multiple sclerosis treatment.
    • Lowering CSF IgG levels could be a therapeutic target in MS management.